(Q44217529)

30 November 2017

title

Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A O/W-emulsion in rats (English)

1 reference

30 November 2017

1 reference

1 reference

1 reference

Soo-Jin Kim

1

1 reference

30 November 2017

Hoo-Kyun Choi

series ordinal

2

1 reference

30 November 2017

Yong-Bok Lee

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

International Journal of Pharmaceutics

30 November 2017

published in

1 reference

30 November 2017

volume

249

1 reference

30 November 2017

issue

1-2

1 reference

30 November 2017

page(s)

149-156

1 reference

Assessment of cyclosporin A in whole blood and plasma in five patients with different hematocrits

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Pharmacodynamic monitoring of cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Absorption and disposition of colloidal drug delivery systems. I. High-performance liquid chromatographic (HPLC) analysis of a cyclosporin emulsion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Comparison of four basic models of indirect pharmacodynamic responses

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Enhancement of the oral absorption of cyclosporin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Cyclosporine neurotoxicity: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Role of dosage regimen in controlling indirect pharmacodynamic responses

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

A step-wise expansion of intestinal intraepithelial T lymphocytes in association with microbial colonization is defined by sensitivity to cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Performance of sonication and microfluidization for liquid-liquid emulsification

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Suppression of inflammation by cyclosporin A is mediated via a T lymphocyte-independent process

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Cyclosporine A in fat emulsion carrier: immunosuppressive effect in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Cyclosporin A in fat emulsion carriers: experimental studies on pharmacokinetics and tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

Studies on the cyclosporin A loaded stearic acid nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900490-8

7 January 2021

10.1016/S0378-5173(02)00490-8

Identifiers

DOI

1 reference

30 November 2017

1 reference